NASDAQ · Biotechnology

Skye Bioscience, Inc. Common Stock (SKYE)

$1.77 +12.42%

Add alert

34 In band Daily RSI (14) · 18 Sep 2026

Moving averages

SMA 200$6.44-72.59%

Company profile

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapeutic drugs that modulate the endocannabinoid system. The company is headquartered in San Diego, California.

SectorHealthcare

IndustryBiotechnology

Market cap$7.86M

P/E ratioNone

EPS$-9.32

Beta2.99

Dividend yield0.00%

52-week high$4.99

52-week low$0.26

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 44 VRTX Vertex Pharmaceuticals Inc RSI 41 CRSP CRISPR Therapeutics AG RSI 55 IOVA Iovance Biotherapeutics Inc RSI 76 RXRX Recursion Pharmaceuticals Inc - Class A RSI 62 MRNA Moderna Inc RSI 63 VKTX Viking Therapeutics Inc RSI 31 SRPT Sarepta Therapeutics Inc RSI 50 EDIT Editas Medicine Inc RSI 43 NVAX Novavax Inc RSI 62

Free forever

RSI alerts for SKYE

Get an email the moment Skye Bioscience, Inc. Common Stock crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 31 August 2026 at 3:49 AM EDT